Lubricant eye drops used to treat the dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations.
The global Eye Drops (Artificial Tear) market was valued at US$ 3151 million in 2023 and is anticipated to reach US$ 4090.1 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.
The artificial tears and lubricants market is driven by the increasing prevalence of dry eye syndrome and the growing awareness of the importance of ocular health. Artificial tears and lubricants are eye drops and ointments used to alleviate dryness and discomfort in the eyes caused by various factors, including aging, digital device use, and environmental conditions. The rise in the aging population and the prevalence of conditions like Sj枚gren's syndrome contribute to market growth as artificial tears provide relief and improve ocular surface health. Moreover, advancements in formulation technology and the development of preservative-free and longer-lasting products have enhanced their efficacy and patient compliance. However, the market also faces challenges, including the need for proper diagnosis and patient education to ensure appropriate product selection and usage. Additionally, addressing competition from alternative dry eye treatments and maintaining affordable pricing can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and effective artificial tears and lubricants, collaborate with eye care professionals to promote their benefits, and address the challenges to meet the increasing demand for ocular health solutions.
This report aims to provide a comprehensive presentation of the global market for Eye Drops (Artificial Tear), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eye Drops (Artificial Tear).
Report Scope
The Eye Drops (Artificial Tear) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Eye Drops (Artificial Tear) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eye Drops (Artificial Tear) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Alcon
Novartis
Santen Pharma
Johnson & Johnson
Bausch & Lomb
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group
Segment by Type
Allergy Eye Care
Standard Eye Care
Segment by Application
Pharmacy
Internet
Grocery
Optical Chains
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Eye Drops (Artificial Tear) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Eye Drops (Artificial Tear) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Eye Drops (Artificial Tear) Market Overview
1.1 Product Overview and Scope of Eye Drops (Artificial Tear)
1.2 Eye Drops (Artificial Tear) Segment by Type
1.2.1 Global Eye Drops (Artificial Tear) Market Value Comparison by Type (2024-2030)
1.2.2 Allergy Eye Care
1.2.3 Standard Eye Care
1.3 Eye Drops (Artificial Tear) Segment by Application
1.3.1 Global Eye Drops (Artificial Tear) Market Value by Application: (2024-2030)
1.3.2 Pharmacy
1.3.3 Internet
1.3.4 Grocery
1.3.5 Optical Chains
1.4 Global Eye Drops (Artificial Tear) Market Size Estimates and Forecasts
1.4.1 Global Eye Drops (Artificial Tear) Revenue 2019-2030
1.4.2 Global Eye Drops (Artificial Tear) Sales 2019-2030
1.4.3 Global Eye Drops (Artificial Tear) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Eye Drops (Artificial Tear) Market Competition by Manufacturers
2.1 Global Eye Drops (Artificial Tear) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Eye Drops (Artificial Tear) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Eye Drops (Artificial Tear) Average Price by Manufacturers (2019-2024)
2.4 Global Eye Drops (Artificial Tear) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Eye Drops (Artificial Tear), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Eye Drops (Artificial Tear), Product Type & Application
2.7 Eye Drops (Artificial Tear) Market Competitive Situation and Trends
2.7.1 Eye Drops (Artificial Tear) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Eye Drops (Artificial Tear) Players Market Share by Revenue
2.7.3 Global Eye Drops (Artificial Tear) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Eye Drops (Artificial Tear) Retrospective Market Scenario by Region
3.1 Global Eye Drops (Artificial Tear) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Eye Drops (Artificial Tear) Global Eye Drops (Artificial Tear) Sales by Region: 2019-2030
3.2.1 Global Eye Drops (Artificial Tear) Sales by Region: 2019-2024
3.2.2 Global Eye Drops (Artificial Tear) Sales by Region: 2025-2030
3.3 Global Eye Drops (Artificial Tear) Global Eye Drops (Artificial Tear) Revenue by Region: 2019-2030
3.3.1 Global Eye Drops (Artificial Tear) Revenue by Region: 2019-2024
3.3.2 Global Eye Drops (Artificial Tear) Revenue by Region: 2025-2030
3.4 North America Eye Drops (Artificial Tear) Market Facts & Figures by Country
3.4.1 North America Eye Drops (Artificial Tear) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Eye Drops (Artificial Tear) Sales by Country (2019-2030)
3.4.3 North America Eye Drops (Artificial Tear) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Eye Drops (Artificial Tear) Market Facts & Figures by Country
3.5.1 Europe Eye Drops (Artificial Tear) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Eye Drops (Artificial Tear) Sales by Country (2019-2030)
3.5.3 Europe Eye Drops (Artificial Tear) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Eye Drops (Artificial Tear) Market Facts & Figures by Country
3.6.1 Asia Pacific Eye Drops (Artificial Tear) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Eye Drops (Artificial Tear) Sales by Country (2019-2030)
3.6.3 Asia Pacific Eye Drops (Artificial Tear) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Eye Drops (Artificial Tear) Market Facts & Figures by Country
3.7.1 Latin America Eye Drops (Artificial Tear) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Eye Drops (Artificial Tear) Sales by Country (2019-2030)
3.7.3 Latin America Eye Drops (Artificial Tear) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Eye Drops (Artificial Tear) Market Facts & Figures by Country
3.8.1 Middle East and Africa Eye Drops (Artificial Tear) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Eye Drops (Artificial Tear) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Eye Drops (Artificial Tear) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Eye Drops (Artificial Tear) Sales by Type (2019-2030)
4.1.1 Global Eye Drops (Artificial Tear) Sales by Type (2019-2024)
4.1.2 Global Eye Drops (Artificial Tear) Sales by Type (2025-2030)
4.1.3 Global Eye Drops (Artificial Tear) Sales Market Share by Type (2019-2030)
4.2 Global Eye Drops (Artificial Tear) Revenue by Type (2019-2030)
4.2.1 Global Eye Drops (Artificial Tear) Revenue by Type (2019-2024)
4.2.2 Global Eye Drops (Artificial Tear) Revenue by Type (2025-2030)
4.2.3 Global Eye Drops (Artificial Tear) Revenue Market Share by Type (2019-2030)
4.3 Global Eye Drops (Artificial Tear) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Eye Drops (Artificial Tear) Sales by Application (2019-2030)
5.1.1 Global Eye Drops (Artificial Tear) Sales by Application (2019-2024)
5.1.2 Global Eye Drops (Artificial Tear) Sales by Application (2025-2030)
5.1.3 Global Eye Drops (Artificial Tear) Sales Market Share by Application (2019-2030)
5.2 Global Eye Drops (Artificial Tear) Revenue by Application (2019-2030)
5.2.1 Global Eye Drops (Artificial Tear) Revenue by Application (2019-2024)
5.2.2 Global Eye Drops (Artificial Tear) Revenue by Application (2025-2030)
5.2.3 Global Eye Drops (Artificial Tear) Revenue Market Share by Application (2019-2030)
5.3 Global Eye Drops (Artificial Tear) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Allergan Eye Drops (Artificial Tear) Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Alcon
6.2.1 Alcon Corporation Information
6.2.2 Alcon Description and Business Overview
6.2.3 Alcon Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Alcon Eye Drops (Artificial Tear) Product Portfolio
6.2.5 Alcon Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Eye Drops (Artificial Tear) Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Santen Pharma
6.4.1 Santen Pharma Corporation Information
6.4.2 Santen Pharma Description and Business Overview
6.4.3 Santen Pharma Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Santen Pharma Eye Drops (Artificial Tear) Product Portfolio
6.4.5 Santen Pharma Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Johnson & Johnson Eye Drops (Artificial Tear) Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 Bausch & Lomb
6.6.1 Bausch & Lomb Corporation Information
6.6.2 Bausch & Lomb Description and Business Overview
6.6.3 Bausch & Lomb Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bausch & Lomb Eye Drops (Artificial Tear) Product Portfolio
6.6.5 Bausch & Lomb Recent Developments/Updates
6.7 Thea pharmaceuticals
6.6.1 Thea pharmaceuticals Corporation Information
6.6.2 Thea pharmaceuticals Description and Business Overview
6.6.3 Thea pharmaceuticals Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Thea pharmaceuticals Eye Drops (Artificial Tear) Product Portfolio
6.7.5 Thea pharmaceuticals Recent Developments/Updates
6.8 URSAPHARM
6.8.1 URSAPHARM Corporation Information
6.8.2 URSAPHARM Description and Business Overview
6.8.3 URSAPHARM Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 URSAPHARM Eye Drops (Artificial Tear) Product Portfolio
6.8.5 URSAPHARM Recent Developments/Updates
6.9 SIMILASAN
6.9.1 SIMILASAN Corporation Information
6.9.2 SIMILASAN Description and Business Overview
6.9.3 SIMILASAN Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 SIMILASAN Eye Drops (Artificial Tear) Product Portfolio
6.9.5 SIMILASAN Recent Developments/Updates
6.10 Akorn
6.10.1 Akorn Corporation Information
6.10.2 Akorn Description and Business Overview
6.10.3 Akorn Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Akorn Eye Drops (Artificial Tear) Product Portfolio
6.10.5 Akorn Recent Developments/Updates
6.11 United Laboratories
6.11.1 United Laboratories Corporation Information
6.11.2 United Laboratories Eye Drops (Artificial Tear) Description and Business Overview
6.11.3 United Laboratories Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 United Laboratories Eye Drops (Artificial Tear) Product Portfolio
6.11.5 United Laboratories Recent Developments/Updates
6.12 Sun Pharmaceutical
6.12.1 Sun Pharmaceutical Corporation Information
6.12.2 Sun Pharmaceutical Eye Drops (Artificial Tear) Description and Business Overview
6.12.3 Sun Pharmaceutical Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sun Pharmaceutical Eye Drops (Artificial Tear) Product Portfolio
6.12.5 Sun Pharmaceutical Recent Developments/Updates
6.13 Jianfeng Group
6.13.1 Jianfeng Group Corporation Information
6.13.2 Jianfeng Group Eye Drops (Artificial Tear) Description and Business Overview
6.13.3 Jianfeng Group Eye Drops (Artificial Tear) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Jianfeng Group Eye Drops (Artificial Tear) Product Portfolio
6.13.5 Jianfeng Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Eye Drops (Artificial Tear) Industry Chain Analysis
7.2 Eye Drops (Artificial Tear) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Eye Drops (Artificial Tear) Production Mode & Process
7.4 Eye Drops (Artificial Tear) Sales and Marketing
7.4.1 Eye Drops (Artificial Tear) Sales Channels
7.4.2 Eye Drops (Artificial Tear) Distributors
7.5 Eye Drops (Artificial Tear) Customers
8 Eye Drops (Artificial Tear) Market Dynamics
8.1 Eye Drops (Artificial Tear) Industry Trends
8.2 Eye Drops (Artificial Tear) Market Drivers
8.3 Eye Drops (Artificial Tear) Market Challenges
8.4 Eye Drops (Artificial Tear) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Allergan
Alcon
Novartis
Santen Pharma
Johnson & Johnson
Bausch & Lomb
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Akorn
United Laboratories
Sun Pharmaceutical
Jianfeng Group
听
听
*If Applicable.